Thomas D. DeByle - Nov 15, 2023 Form 4 Insider Report for CHASE CORP (CCF)

Role: Director
Signature: Paula M Myers, By Power of Attorney
Stock symbol: CCF
Transactions as of: Nov 15, 2023
Transactions value $: $0
Form type: 4
Date filed: 11/15/2023, 07:22 PM
Previous filing: Feb 9, 2023
Next filing: Jun 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CCF	Chase Corporation Common Stock	Disposed to Issuer		-3.89K	-100%		0	Nov 15, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Thomas D. DeByle is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger, dated as of July 21, 2023, by and among Chase Corporation (the "Issuer"), Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation, a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, effective as of November 15, 2023 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each issued and outstanding share of the Issuer's Common Stock (each, a "Share") was cancelled and converted into the right to receive $127.50 in cash (the "Per Share Consideration"), subject to any applicable withholding of taxes and without interest.
F2	In accordance with the Merger Agreement, all shares underlying the restricted stock awards granted to the Reporting Person vested as of the Effective Time and were cancelled and converted into the right to receive a cash payment, without interest, in an amount equal to the Per Share Consideration, subject to any applicable withholding of taxes.

Content

This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger, dated as of July 21, 2023, by and among Chase Corporation (the "Issuer"), Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation, a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, effective as of November 15, 2023 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each issued and outstanding share of the Issuer's Common Stock (each, a "Share") was cancelled and converted into the right to receive $127.50 in cash (the "Per Share Consideration"), subject to any applicable withholding of taxes and without interest.

In accordance with the Merger Agreement, all shares underlying the restricted stock awards granted to the Reporting Person vested as of the Effective Time and were cancelled and converted into the right to receive a cash payment, without interest, in an amount equal to the Per Share Consideration, subject to any applicable withholding of taxes.